Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patientsWilma Barcellini, Alberto Zanella, Bruno Fattizzo et al.|Blood|2014Cited by 371
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic AnemiaWilma Barcellini, Bruno Fattizzo|Disease Markers|2015Cited by 281
Cold agglutinin disease revisited: a multinational, observational study of 232 patientsSigbjørn Berentsen, Geir E. Tjønnfjord, Wilma Barcellini et al.|Blood|2020Cited by 167
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studiesWilma Barcellini, Alberto Zanella, Francesca Guia Imperiali et al.|Blood|2012Cited by 144
The Changing Landscape of Autoimmune Hemolytic AnemiaWilma Barcellini, Bruno Fattizzo|Frontiers in Immunology|2020Cited by 141